Table 2.
Gene set size | Overlap | Enrichment ratio | p | FDR | Included genes | |
---|---|---|---|---|---|---|
GO terms | ||||||
Neuronal cell body | 486 | 29 | 2.08 | 1.0E−04 | 0.025 | CAD, CHRNA3, CRTC1, CYP17A1, DDN, DGKI, DRD2, EEF1A2, FXR2, GNAT1, GNRH1, GRIK5, HPCA, ITPR3, KCNN2, KIF5A, KLC1, MAPK1, NRXN1, PARD3, PDE1C, PSEN1, RPTOR, RTN4, RTN4RL1, SLC1A3, SLC4A10, UCHL1, SHTN1 |
Pathways | ||||||
Hemostasis | 620 | 38 | 2.25 | 2.1E−06 | 0.004 | AK3, AKAP10, ALDOA, ATP2A1, ATP2A2, ATP2B2, CBX5, CDC37L1, CSK, DAGLA, DGKG, DGK1, ECM1, ITGAL, ITGB3, ITIH3, ITIH4, ITPR3, KIF5A, KLC1, MAPK1, MAPK3, MFN2, NEF2, OLA1, PDE3B, PLCG1, PPIL2, PRKACA, SH2B1, SLC7A6, SLC8A1, TUBA1A, TUBA1B, TUBA1C, TUBA4A, VCL, ZFPM2 |
Signaling by Hedgehog | 147 | 14 | 3.50 | 4.8E−05 | 0.020 | ADCY9, DERL2, IFT172, IFT57, PRKACA, PSMA5, PSMB10, RPGRIP1L, SUFU, TUBA1A, TUBA1B, TUBA1C, TUBA4A, ULK3 |
L1CAM interactions | 117 | 12 | 3.76 | 8.1E−05 | 0.020 | ITGB3, KCNQ2, MAP2K1, MAPK1, MAPK3, NCAM1, RPS6KA5, SHTN1, TUBA1A, TUBA1B, TUBA1C, TUBA4A |
Signaling by BRAF and RAF fusions | 60 | 8 | 4.89 | 0.0002 | 0.030 | CSK, ITGB3, MAP2K1, MAPK1, MAPK3, MARK3, QKI, VCL |
Enriched GO terms and REACTOME pathways were obtained using the weighted set cover method implemented by WebGestalt, which reduces redundancy of the gene sets
BMI body mass index, FDR false discovery rate